Sensei Biotherapeutics (SNSE) Stock Statistics & Valuation Metrics

Sensei Biotherapeutics has a market cap or net worth of $26.70M. The enterprise value is -$127.71M.

Sensei Biotherapeutics has 1,341,140 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sensei Biotherapeutics’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -110.88%.

The current PE Ratio of Sensei Biotherapeutics is ―. Sensei Biotherapeutics’s PEG ratio is -0.00049.

In the last 12 months, Sensei Biotherapeutics had revenue of 0.00 and earned -21.09M in profits. Earnings per share was -16.72.

In the last 12 months, operating cash flow was -24.09M and capital expenditures -22.00K, giving a free cash flow of -24.11M billion.

Sensei Biotherapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Sensei Biotherapeutics upcoming earnings date is Aug 11, 2026, Before Open (Confirmed).

Sensei Biotherapeutics as a current ratio of 5.06, with Debt / Equity ratio of -0.76%

In the past 12 months, Sensei Biotherapeutics has paid 0.00 in taxes.

Sensei Biotherapeutics EV to EBITDA ratio is -0.30, with an EV/FCF ratio of -0.31.

Sensei Biotherapeutics has $202.79M in cash and marketable securities with $1.04M in debt, giving a net cash position of $201.75M billion.

Gross margin is 2740.82%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Sensei Biotherapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―